These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

144 related items for PubMed ID: 2663323

  • 21. Serum osteoprotegerin and its ligand in Paget's disease of bone: relationship to disease activity and effect of treatment with bisphosphonates.
    Alvarez L, Peris P, Guañabens N, Vidal S, Ros I, Pons F, Filella X, Monegal A, Muñoz-Gomez J, Ballesta AM.
    Arthritis Rheum; 2003 Mar; 48(3):824-8. PubMed ID: 12632438
    [Abstract] [Full Text] [Related]

  • 22. Clinical, biochemical, hematologic, and radiographic responses in Paget's disease following intravenous pamidronate disodium: a 2-year study.
    Gutteridge DH, Retallack RW, Ward LC, Stuckey BG, Stewart GO, Prince RL, Kent GN, Bhagat CI, Price RI, Thompson RI, Nicholson GC.
    Bone; 1996 Oct; 19(4):387-94. PubMed ID: 8894145
    [Abstract] [Full Text] [Related]

  • 23. Comparison of methods of assessing response of Paget's disease to bisphosphonate therapy.
    Patel S, Coupland CA, Stone MD, Hosking DJ.
    Bone; 1995 Feb; 16(2):193-7. PubMed ID: 7756047
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Long-Term Effects of Intravenous Ibandronate in Paget's Disease of Bone.
    Reid IR, Wattie D, Gamble GD, Kalluru R, Cundy T.
    Calcif Tissue Int; 2017 Mar; 100(3):250-254. PubMed ID: 27866237
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. [Amino-hydroxy-propylidene biphosphonate in the treatment of Paget's disease resistant to calcitonin and/or etidronate].
    Miravet L, Kuntz D.
    Rev Rhum Mal Osteoartic; 1989 Mar 15; 56(4):287-92. PubMed ID: 2496460
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Medical management of Paget's disease of bone: indications for treatment and review of current therapies.
    Siris ES, Lyles KW, Singer FR, Meunier PJ.
    J Bone Miner Res; 2006 Dec 15; 21 Suppl 2():P94-8. PubMed ID: 17229018
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Measurement of bone mineral density by dual X-ray absorptiometry in Paget's disease before and after pamidronate treatment.
    Laroche M, Delpech B, Bernard J, Constantin A, Mazières B.
    Calcif Tissue Int; 1999 Sep 15; 65(3):188-91. PubMed ID: 10441648
    [Abstract] [Full Text] [Related]

  • 33. [Paget's disease: case report].
    Wegierska M, Ignaczak P, Zalewska J, Jeka S.
    Ann Acad Med Stetin; 2011 Sep 15; 57(3):64-9; discussion 69. PubMed ID: 23383549
    [Abstract] [Full Text] [Related]

  • 34. Treatment of Paget's disease of bone with aminohydroxybutylidene bisphosphonate.
    O'Doherty DP, Bickerstaff DR, McCloskey EV, Hamdy NA, Beneton MN, Harris S, Mian M, Kanis JA.
    J Bone Miner Res; 1990 May 15; 5(5):483-91. PubMed ID: 2195845
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Antiresorptive effect of a single infusion of microgram quantities of zoledronate in Paget's disease of bone.
    Arden-Cordone M, Siris ES, Lyles KW, Knieriem A, Newton RA, Schaffer V, Zelenakas K.
    Calcif Tissue Int; 1997 May 15; 60(5):415-8. PubMed ID: 9115157
    [Abstract] [Full Text] [Related]

  • 37. Successful treatment of resistant Paget's disease of bone with pamidronate.
    Mallette LE.
    Arch Intern Med; 1989 Dec 15; 149(12):2765-7. PubMed ID: 2596945
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.